Collegium Pharma (COLL) Misses Q1 EPS by $1.29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Collegium Reports First Quarter 2022 Financial Results
May 10, 2022 4:01 PM EDT- Generated Net Revenue of $83.8 Million -
- Completed BDSI Acquisition; On Track to Exceed Targeted Run Rate Synergies of at Least $75 Million -
- Resolved All Opioid-Industry Litigation -
- Reaffirms 2022 Financial Guidance -
- Conference Call Scheduled for Today at 4:30 p.m. ET -
STOUGHTON, Mass., May 10, 2022 (GLOBE NEWSWIRE) --... More



